May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Induction of Glyoxalase I in Diabetic Mouse Lenses
Author Affiliations & Notes
  • M.M. Staniszewska
    Ophthalmology, Case Western Reserve Univ, Cleveland, OH
  • R.H. Nagaraj
    Ophthalmology, Case Western Reserve Univ, Cleveland, OH
  • Footnotes
    Commercial Relationships  M.M. Staniszewska, None; R.H. Nagaraj, None.
  • Footnotes
    Support  RO1EY–09912, RO106129 HIGHWIRE EXLINK_ID="47:5:4126:1" VALUE="RO106129" TYPEGUESS="GEN" /HIGHWIRE , EYP30–11373, RPB, Ohio Lions Eye Research Foundation
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 4126. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.M. Staniszewska, R.H. Nagaraj; Induction of Glyoxalase I in Diabetic Mouse Lenses . Invest. Ophthalmol. Vis. Sci. 2006;47(13):4126.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Alpha–dicarbonyl compounds methylglyoxal (MGO) and glyoxal (GO) are highly reactive protein modifiers present in the human lens. Several products of their reaction are present in the lens. Such products accumulate in significant quantities in cataractous lenses. Glyoxalase system consisting of glyoxalase I (requires GSH) and glyoxalase II metabolizes α–dicarbonyl compounds to less reactive products. In this study we have investigated the effect of hyperglycemia on the activity of glyoxalase I and its role in MGO metabolism in lens epithelial cells and lenses of streptozotocin–diabetic mice.

Methods: : Primary mouse lens epithelial cells were cultured for 7 days in the presence of 5 or 25 mM D–glucose or 25 mM L–glucose (osmotic control). Glyoxalase I activity was measured spectrophotometrically and its mRNA levels were measured by quantitative PCR. We also measured MGO and reduced GSH in cell lysates. Similar measurements were done in lenses of diabetic mice.

Results: : Glyoxalase I activity in 25 mM D–glucose treated cells was significantly higher when compared cells treated with 5 mM D–glucose or 25 mM L–glucose (mean±SD: 5 mM Glc–120.4±9.7 nmoles S–lactoylglutathione formed per min per mg protein; 25 mM D–Glc–144.7±12.0; 25 mM L–Glc–124.8 ±13.9). Glyoxalase I mRNA content was also significantly higher (P<0.01) in 25 mM D–glucose treated cells (fold change over control– 25 mM Glc–1.72±0.7; 25 mM L–Glc–1.05±0.6). In spite of the higher glyoxalase activity, MGO levels were significantly higher (P=0.007) in cells grown in 25 mM D–glucose when compared cells grown in 5 mM D–glucose or 25 mM L–glucose. GSH levels were considerably reduced in cells cultured with 25 mM D–glucose (nmoles of GSH/mg protein, mean±SD: 5 mM Glc–10.28±1.39; 25 mM D–Glc–9.04±0.39; 25 mM L–Glc–9.53±1.05). In 9–week old diabetic mouse lenses, the glyoxalase I activity and mRNA content were significantly higher than in non–diabetic control animals (glyoxalase I: control–137.8±11.1; Diab–161.1±24.2, P=0.003; fold change in glyoxalase I mRNA in diabetic lenses–1.31±0.2).

Conclusions: : Induction of glyoxalase I may constitute an initial protective response against damaging effects of hyperglycemia in diabetes. Reduction in the GSH content in diabetic lenses may compromise MGO metabolism by this protective enzyme.

Keywords: diabetes • enzymes/enzyme inhibitors • protective mechanisms 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.